International Multicenter Study on SMILE Surgery

Sponsor
Tianjin Eye Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02844556
Collaborator
Nethradhama Superspeciality Eye Hospital (Other), Alexandria University (Other), Belgian Ocular Laser Centre (Other), Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (Other), Jinan Mingshui Eye Hospital (Other)
1,000
1
2
39
25.7

Study Details

Study Description

Brief Summary

The purpose of this study is to carry out an international multicenter trial to get more convincing and valuable results of the SMILE surgery and compare the outcomes between the SMILE surgery and the FS-LASIK (femtosecond laser assisted-laser in situ keratomileusis) surgery.

The investigators hope to investigate the differences between the SMILE and the FS-LASIK surgery comprehensively, including the comparison of visual acuity, refraction, the correction of cylindrical diopter, the high order aberrations, the corneal biomechanics, the corneal ectasia, the characteristics of the changes of central corneal thickness and the complications. To meet the demands of a multi center trial, all the examination equipments should be same in each center, and this will limit the variations within a study

Condition or Disease Intervention/Treatment Phase
  • Procedure: SMILE surgery
  • Other: FS-LASIK surgery
N/A

Detailed Description

Hypothesis: To compare the novel refractive surgery (SMILE, the intervention group) with traditional refractive surgery (FS-LASIK, the control group) in terms of visual acuity, the higher order aberrations, corneal biomechanical parameters and the complications. SMILE surgery might offer some advantages in some aspects compared with FS-LASIK surgery.

Study program

The procedures of the study are listed as follows:

All the participants accept the refractive surgery which were selected at first, and patients' routine postoperative examinations included UCVA, BCVA, slit lamp microscopy, non-contact IOP, corneal topography with the Scheimpflug tomography system, ocular higher order aberrations using the WASCA analyzer (Carl Zeiss Meditec AG), corneal biomechanical properties acquired by the Ocular Response Analyzer and/or the Corvis ST (Corvis ST, OCULUS, Wetzlar, Germany) at 1 week, 1 month, 3 months and 6 months follow-up periods after surgery.

Statistics:

Patients who have decided to choose the SMILE surgery or the FS-LASIK will be selected as participants. The propensity matching method will be used to choose proper cases for the two groups. The propensity matching method can be calculated by SPSS software. The independent variables include: the central corneal thickness (CCT), the Km (mean Pentacam keratometry), the spherical diopter (from manifest refraction), and the cylindrical diopter (from manifest refraction), the UCVA, the BCVA, the corneal resistance factor (CRF) and the corneal hysteresis (CH) (if the investigator have the Ocular Response Analyzer) of the cornea at preoperative. The closest score of eyes in the two groups will be matched.

The data will be preserved by each site, and will be systematically collected and analyzed by TianjinEH center. The statistical expert Dr Hayes from American Pacific University will be the statistical consultant, and will also in charge of the sample size calculation, the instructor of statistical analysis, and the quality control.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1000 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
International Multicenter Study on Small Incision Lenticule Extraction(SMILE) Surgery
Study Start Date :
Sep 1, 2016
Anticipated Primary Completion Date :
Sep 1, 2019
Anticipated Study Completion Date :
Dec 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Other: SMILE surgery

Small incision lenticule extraction (SMILE) has become a novel and effective method for the correction of myopia and myopic astigmatism. It is a micro-invasive and flapless refractive procedure that has been proved to offer many advantages in terms of visual acuity, corneal sensitivity and corneal biomechanics compared with traditional refractive surgeries.

Procedure: SMILE surgery
SMILE surgery and FS-LASIK surgery are both effective method for the correction of myopia and myopic astigmatism. They have been proved to offer many advantages in terms of visual acuity, corneal sensitivity and corneal biomechanics compared with traditional refractive surgeries.

Other: FS-LASIK surgery

FS-LASIK surgery is femtosecond laser assisted- conventional refractive surgery and has also been proved to offer many advantages in terms of visual acuity, corneal sensitivity and corneal biomechanics compared with traditional refractive surgeries.

Other: FS-LASIK surgery
SMILE surgery and FS-LASIK surgery are both effective method for the correction of myopia and myopic astigmatism. They have been proved to offer many advantages in terms of visual acuity, corneal sensitivity and corneal biomechanics compared with traditional refractive surgeries.

Outcome Measures

Primary Outcome Measures

  1. corrected visual acuity [change from baseline with EDTRS chart at 6 months]

Secondary Outcome Measures

  1. uncorrected visual acuity [change from baseline with EDTRS chart at 6 months]

  2. spherical diopter [change from baseline with manifest refraction at 6 months]

  3. cylindrical dioptor [change from baseline with manifest refraction at 6 months]

  4. central corneal thickness [change from baseline with the Pentacam system at 6 months]

  5. corneal curvature assessed by the Pentacam system [change from baseline with mean Pentacam keratometry at 6 months]

  6. corneal resistance factor assessed by the Ocular Response Analyzer [change from baseline at 6 months]

  7. corneal hysteresis assessed by the Ocular Response Analyzer [change from baseline at 6 months]

  8. deformation amplitude assessed by the Corvis ST system [change from baseline at 6 months]

  9. spherical aberration [change from baseline with the WASCA system at 6 months]

  10. coma aberration [change from baseline with the WASCA system at 6 months]

  11. complication [intraoperative and postoperative at 6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • be accompanied by a parent or guardian who is able to give informed consent as demonstrated by signing a record of informed consent;

  • at baseline, be within the age range of 18 to 45 years old inclusive

  • normal corneal morphology with no corneal nebula or corneal macula, the range of preoperative K2 (the steep curvature of the 3mm area at the center of cornea) from 38.0 to 47.0 diopter

  • manifest spherical equivalent of -1.0 to -10.0 diopters (D)

  • cylindrical diopter no more than -5.0D

  • refractive diopter maintained stable for more than2 years

  • preoperative BCVA≥0.8, and the scotopic pupil diameter≥5.0mm when measured by WASCA analyzer (Carl Zeiss Meditec AG)

  • picked off soft contact lens for more than 2 weeks

  • picked off RGP for more than 1 month

  • preoperative corneal central thickness measured by Pentacam >500μm, non-contact IOP<21mmHg

  • be willing to comply with the clinical trial visit schedule as directed by the investigator.

Exclusion Criteria:
  • any corneal diseases, corneal operations, eyes trauma or systemic diseases history; keratoconus or tendency of keratoconus

  • corneal macula and obvious pannus; current enrolment in another clinical trial/research project.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tianjin Eye Hospital Tianjin China

Sponsors and Collaborators

  • Tianjin Eye Hospital
  • Nethradhama Superspeciality Eye Hospital
  • Alexandria University
  • Belgian Ocular Laser Centre
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
  • Jinan Mingshui Eye Hospital

Investigators

  • Study Director: Yan Wang, director, Tianjin Eye Hospital
  • Principal Investigator: Sri Ganesh, professor, Nethradhama Superspeciality Eye Hospital
  • Principal Investigator: Bernard Heintz, professor, Belgian Ocular Laser Centre
  • Principal Investigator: Osama Ibrahim, professor, Cornea Center, Alexandria University
  • Principal Investigator: Keming Yu, professor, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
  • Principal Investigator: Yulin Lei, professor, Jinan Mingshui Eye Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Tianjin Eye Hospital
ClinicalTrials.gov Identifier:
NCT02844556
Other Study ID Numbers:
  • Tianjin EH-SMILE
First Posted:
Jul 26, 2016
Last Update Posted:
May 4, 2018
Last Verified:
May 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Tianjin Eye Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 4, 2018